Stock Earnings

Question 1

Krystal Biotech Inc'in temel mali tabloları nelerdir?

Accepted Answer

Son mali tabloya (Form-10K) göre, Krystal Biotech Inc'in toplam varlıkları $1,055 olup, net profit $89'dir.

Question 2

KRYS'ün temel finansal oranları nelerdir?

Accepted Answer

Krystal Biotech Inc'in cari oranı 9.67, net kâr marjı 30.68, hisse başına satış $9.75'dir.

Question 3

Krystal Biotech Inc'in geliri segment veya coğrafya bazında nasıl dağılıyor?

Accepted Answer

Krystal Biotech Inc largest revenue segment is Genetic Medicines, at a revenue of 290,515,000 in the most earnings release.For geography, United States is the primary market for Krystal Biotech Inc, at a revenue of 290,515,000.

Question 4

Krystal Biotech Inc kârlı mı?

Accepted Answer

yes, son mali tablolara göre Krystal Biotech Inc'in net profit $89'dir.

Question 5

Krystal Biotech Inc'in herhangi bir yükümlülüğü var mı?

Accepted Answer

yes, Krystal Biotech Inc'in yükümlülüğü 109'dir.

Question 6

Krystal Biotech Inc'in tedavüldeki hisse sayısı kaçtır?

Accepted Answer

Krystal Biotech Inc'in toplam tedavüldeki hisse sayısı 28.79'dir.

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	359	290	50	0	0	0
Revenue Growth (YoY)	115.99%	480%	--	--	--	--
Cost of Revenue	23	20	3	--	--	--
Gross Profit	335	270	47	--	--	--
Selling, General & Admin	127	113	98	77	40	15
Research & Development	55	53	46	42	27	17
Operating Expenses	183	167	144	120	68	33
Other Non Operating Income (Expenses)	--	--	--	--	--	--
Pretax Income	168	95	12	-139	-69	-32
Income Tax Expense	22	6	1	--	--	--
Net Income	146	89	10	-139	-69	-32
Net Income Growth	39%	790%	-107%	101%	115.99%	68%
Shares Outstanding (Diluted)	29.74	29.74	27.75	25.49	22.2	18.79
Shares Change (YoY)	0%	7%	9%	15%	18%	18%
EPS (Diluted)	4.91	2.99	0.39	-5.49	-3.13	-1.71
EPS Growth	38%	661%	-107%	75%	83%	43%
Free Cash Flow	185	119	-100	-153	-116	-40
Free Cash Flow Per Share	6.21	4	-3.6	-6	-5.22	-2.12
Gross Margin	93.31%	93.1%	94%	--	--	--
Operating Margin	42.06%	35.51%	-194%	0%	0%	0%
Profit Margin	40.66%	30.68%	20%	0%	0%	0%
Free Cash Flow Margin	51.53%	41.03%	-200%	0%	0%	0%
EBITDA	156	108	-92	-116	-66	-32
EBITDA Margin	43.45%	37.24%	-184%	0%	0%	0%
D&A For EBITDA	5	5	5	4	2	1
EBIT	151	103	-97	-120	-68	-33
EBIT Margin	42.06%	35.51%	-194%	0%	0%	0%
Effective Tax Rate	13.09%	6.31%	8.33%	--	--	--

Krystal Biotech Inc (KRYS) Price

KRYS Stock Price Chart

KRYS Income

Follow-Up Questions